Furthermore, elevated SAMD4B mRNA levels were observed in clinical stages I, II, and III of breast cancer; however, no significant difference in its expression was detected in stage IV of breast cancer (Figure 1C), indicating that further verification of SAMD4B expression level in clinical breast cancer samples is still needed. The gene discussed is SAMD4B; the disease is breast cancer.